We build technology that enhances therapeutic care and patient management

We build technology that enhances therapeutic care and patient management

At Bio Conscious, we’re redefining how glucose data is used—translating numbers into meaningful insights that help clinicians make confident decisions.

Since 2015, we’ve been building AI-driven solutions that don’t just track health but help shape its future. By bridging the gap between data and action, we empower better care, earlier intervention, and a deeper understanding of metabolic health.

At Bio Conscious, we’re redefining how glucose data is used—translating numbers into meaningful insights that help clinicians make confident decisions.

Bio Conscious Glucose
Bio Conscious Glucose

Millions Track Their Glucose But What Comes Next?

Millions Track Their Glucose But What Comes Next?

Millions Track Their Glucose But What Comes Next?

Millions of people monitor their glucose daily, yet most of this data remains unused beyond diabetes management. Traditional healthcare reacts to problems rather than preventing them, leaving many patients unaware of metabolic issues until it’s too late.

THE BIO CONSCIOUS DIFFERENCE

From Data to Action

From Data to Action

From Data to Action

Glucose data should do more than record numbers, it should guide life decisions. Our AI translates continuous glucose data into actionable insights, helping clinics optimize care, catch risks earlier, and scale their impact.

WHERE WE'RE HEADED

From Vancouver to the World.

From Vancouver to the World.

From Vancouver to the World.

Founded in Vancouver, Bio Conscious Technologies empowers clinics across North America. We are transforming healthcare enabling clinics to identify and protect patients from chronic disease using AI-driven glucose insights.

WHAT MAKES US DIFFERENT

We Predict and Prevent

We Predict and Prevent

We Predict and Prevent

Most AI solutions focus on detecting risks. We take it further—helping clinics take action to prevent chronic disease before it starts, improving patient outcomes while enhancing clinic efficiency.

Where Advanced Algorithms Meet Human Health

Our algorithms analyze and model metabolic behavior to better calculate likely future metabolic outcome.

Understanding glucose metabolism to help patients manage diabetes is our core focus. Additionally, our AI–Technology is applicable to conditions ranging from heart disease to hypertension, dementia, and more.

We strive to create a symphony of algorithms to provide users with a complete picture of their health with personalized and actionable insights.

Our algorithms analyze and model metabolic behavior to better calculate likely future metabolic outcome.

Understanding glucose metabolism to help patients manage diabetes is our core focus. Additionally, our AI–Technology is applicable to conditions ranging from heart disease to hypertension, dementia, and more.

We strive to create a symphony of algorithms to provide users with a complete picture of their health with personalized and actionable 
insights.

How we got here

2024

BioConscious Technologies partnered with Dexcom, a global leader in continuous glucose monitoring, to explore new frontiers in AI-driven chronic disease prevention. At the 84th ADA Conference, we unveiled cutting-edge research, bridging the gap between glucose monitoring and predictive healthcare.

2020 – 2022

As AI in healthcare gained traction, we continued showcasing our advancements at the 80th, 81st, and 82nd ADA Conferences. Our work emphasized the shift from reactive treatment to proactive, data-driven prevention, reinforcing our role as pioneers in metabolic health.

2019

We introduced Endobits, a clinician-first AI platform designed to streamline diabetes management in healthcare settings. By integrating predictive models and automated workflows, Endobits empowered medical professionals to improve patient outcomes efficiently.

2018 – 2019

Our research was recognized at the 78th and 79th American Diabetes Association (ADA) Scientific Sessions, where we demonstrated how AI could forecast glucose fluctuations and provide real-time insights. These early successes validated our technology’s potential in clinical care.

2017

We launched Diabits, an AI-powered glucose prediction app that allowed users to anticipate glucose trends up to 3 hours ahead. This breakthrough gave people with diabetes a new level of control over their health, setting the foundation for our future innovations.

2016

Founded in Vancouver, Canada, Bio Conscious Technologies was born from a vision to move beyond traditional glucose monitoring. We set out to harness AI and predictive analytics to transform how clinicians and patients understand metabolic health.

Bio Conscious believes that glucose data holds untapped potential not just for diabetes management but for transforming how we prevent and treat chronic disease.

Our technology empowers clinics with intelligent insights, making personalized care more efficient and proactive.

Bio Conscious believes that glucose data holds untapped potential not just for diabetes management but for transforming how we prevent and treat chronic disease.

Our technology empowers clinics with intelligent insights, making personalized care more efficient and proactive.

© 2015 - 2025 Bio Conscious Technologies Inc.

© 2015 - 2025 Bio Conscious Technologies Inc.

© 2015 - 2025 Bio Conscious Technologies Inc.

© 2015 - 2025 Bio Conscious Technologies Inc.